EKF Diagnostics Holdings Plc
Research EKF Diagnostics Holdings Plc (EKF) on Bullrun: market cap GBX 11.62B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEKF
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryMedical Devices
- CurrencyGBX
- Market capGBX 11.62B
- Financial periodFY2025
- RevenueGBP 51.56M
- Revenue growth2.7%
- Net incomeGBP 2.12M
- Free cash flowGBP 7.34M
- Gross margin51.4%
Valuation Snapshot
latest market cap is GBX 11.62B.
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic;
Frequently asked questions
What is EKF Diagnostics Holdings Plc's market cap?
EKF Diagnostics Holdings Plc's market capitalization is GBX 11.62B.
What does EKF Diagnostics Holdings Plc do?
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer;